Literature DB >> 20738289

Reproductive aging and its consequences for general health.

Michael L Traub1, Nanette Santoro.   

Abstract

Reproductive aging coincides with endocrine changes that are not solely reproductive in nature and culminates in hypergonadotropic hypogonadism and amenorrhea. These changes are identifiable biochemically regardless of clinical manifestations. Changes in the hypothalamic-pituitary-ovarian axis are associated with changes in other hormonal axes, specifically the adrenal androgen and the somatotropic axis. A large body of literature indicates that reproductive aging is associated with a decline in the somatotropic axis. The interactions between reproductive aging and changes in the adrenal androgen axis are more complex and complicated by age-related declines in the adrenal axis early in the reproductive years. These changes may play an important role in overall health maintenance. Attempts to ameliorate hormonal declines with exogenous hormonal therapy have produced mixed results. Finally, the age-specific timing as well as the rapidity of the changes that occur with reproductive aging seems to have important consequences on metabolism, cardiovascular risk, cognition, bone density, and even mortality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20738289     DOI: 10.1111/j.1749-6632.2010.05521.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  Role of the steroidogenic acute regulatory protein in health and disease.

Authors:  Pulak R Manna; Cloyce L Stetson; Andrzej T Slominski; Kevin Pruitt
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 2.  Oxidative stress and the ageing endocrine system.

Authors:  Giovanni Vitale; Stefano Salvioli; Claudio Franceschi
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

3.  Up-regulation of steroid biosynthesis by retinoid signaling: Implications for aging.

Authors:  Pulak R Manna; Cloyce L Stetson; Carol Daugherty; Ikue Shimizu; Peter J Syapin; Ghislaine Garrel; Joelle Cohen-Tannoudji; Ilpo Huhtaniemi; Andrzej T Slominski; Kevin Pruitt; Douglas M Stocco
Journal:  Mech Ageing Dev       Date:  2015-08-21       Impact factor: 5.432

4.  Menopausal Symptoms and Its Correlates: A Study on Tribe and Caste Population of East India.

Authors:  Doyel Dasgupta; Priyanka Karar; Subha Ray; Nandini Ganguly
Journal:  Curr Gerontol Geriatr Res       Date:  2015-07-30

5.  Efficacy of dehydroepiandrosterone to overcome the effect of ovarian ageing (DITTO): a proof of principle randomised controlled trial protocol.

Authors:  Kannamannadiar Jayaprakasan; Amarin Narkwichean; Walid E Maalouf; Bruce K Campbell
Journal:  BMJ Open       Date:  2014-10-08       Impact factor: 2.692

6.  Generation and assessment of high-quality mouse oocytes and embryos following nicotinamide mononucleotide administration.

Authors:  Yilong Miao; Jingyue Chen; Qian Gao; Bo Xiong
Journal:  STAR Protoc       Date:  2021-01-22

Review 7.  Heterogeneity and Dynamics of Vasculature in the Endocrine System During Aging and Disease.

Authors:  Sina Stucker; Jessica De Angelis; Anjali P Kusumbe
Journal:  Front Physiol       Date:  2021-03-09       Impact factor: 4.566

8.  Aging influences steroid hormone release by mink ovaries and their response to leptin and IGF-I.

Authors:  Alexander V Sirotkin; Dušan Mertin; Karin Süvegová; Abdel Halim Harrath; Jan Kotwica
Journal:  Biol Open       Date:  2016-01-21       Impact factor: 2.422

9.  Age-associated dysregulation of protein metabolism in the mammalian oocyte.

Authors:  Francesca E Duncan; Susmita Jasti; Ariel Paulson; John M Kelsh; Barbara Fegley; Jennifer L Gerton
Journal:  Aging Cell       Date:  2017-10-10       Impact factor: 9.304

10.  What Changed on the Folliculogenesis in the Process of Mouse Ovarian Aging?

Authors:  Wenlei Ye; Wei Shen; Wei Yan; Su Zhou; Jing Cheng; Guangxin Pan; Meng Wu; Lingwei Ma; Aiyue Luo; Shixuan Wang
Journal:  Biomed Res Int       Date:  2019-04-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.